Craniometrix + MIND at Home
®
MIND at Home is one of the best-researched and best-proven models of dementia care in the country. It directly informed the new CMS GUIDE Model.
​
Now, using Craniometrix, providers across the country can get access to MIND at Home, managed by Johns Hopkins Medicine clinicians, and enroll their patients on GUIDE.
​
Using highly-trained social workers and our AI-powered care navigation software with CareGPT , we make it possible to easily surpass GUIDE requirements.​
®
TM
Better care, new revenue.
Through our collaboration with the MIND at Home program, we provide care navigation services to dementia patients – all for free, paid for by Medicare’s new GUIDE Model. Doctors maintain clinical ownership of their patients, and we keep them healthy between appointments with 24/7 support. You can simultaneously improve patient outcomes and unlock hundreds of thousands in new profit per doctor.
Why Choose Craniometrix?
We are driven by a mission to revolutionize dementia care through innovation, technology, and compassion. By integrating data-driven insights with compassionate care, we aim to make dementia more manageable while preserving dignity at every stage.
Innovation-Driven
We leverage AI and cutting-edge technology to provide personalized, effective care solutions.
%203.png)
Patient-Centered Approach
Every feature of the platform is designed with patients' wellbeing and dignity in mind.
Collaborative Care
Healthcare professionals can work together, streamlining communication and improving patient outcomes.
Craniometrix is providing GUIDE in partnership with leading medical institutions and neurologists
Craniometrix is a CMS-approved, certified GUIDE participant and works with leaders in dementia care to deliver our services.
Veteran neurologist oversight
We are under the clinical leadership of Jeffrey Greenberg, MD, who serves as Head of Medical Affairs. Dr. Greenberg has over 25 years of experience treating Alzheimer's and related dementias in private practice.
He has also served as a Principal Investigator for Alzheimer’s Disease clinical trials and has spoken nationally on the topic of caregiver burden and agitation in dementia.
An All-in-One Dementia Care Solution
